CAS 57109-90-7

Clorazepato dipotassico

Descrizione:

Clorazepato dipotassico è un derivato delle benzodiazepine utilizzato principalmente come farmaco ansiolitico e anticonvulsivante. È caratterizzato dalla sua capacità di potenziare gli effetti del neurotrasmettitore acido gamma-aminobutirrico (GABA) sul recettore GABA-A, portando a proprietà sedative, ansiolitiche, miorilassanti e anticonvulsivanti. La sostanza è tipicamente somministrata nella sua forma di sale dipotassico, che migliora la sua solubilità e biodisponibilità. Clorazepato dipotassico è spesso prescritto per il trattamento dei disturbi d'ansia, dei sintomi da astinenza da alcol e di alcuni tipi di crisi. È importante notare che, come altre benzodiazepine, può portare a dipendenza e sintomi da astinenza dopo l'interruzione dopo un uso prolungato. Gli effetti collaterali comuni possono includere sonnolenza, vertigini e compromissione cognitiva. A causa del suo potenziale di abuso e dipendenza, Clorazepato dipotassico è classificato come sostanza controllata in molte giurisdizioni, richiedendo un attento monitoraggio da parte dei professionisti sanitari durante il trattamento.

Formula: C₁₆H₁₁ClK₂N₂O₄

InChI: InChI=1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;;+1;/p-1

InChI key: InChIKey=TVVIGDFTYHGWSG-UHFFFAOYSA-M

SMILES: [K]O.C(O)(=O)C1N=C(C=2C(NC1=O)=CC=C(Cl)C2)C3=CC=CC=C3.[K]

Sinonimi:

• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (1:1)
• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt, compd. with potassium hydroxide (K(OH)) (1:1:1)
• 1H-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, hydroxide, potassium salt (1:1:2)
• 4306Cb
• 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid
• Ab 35616
• Abbott 35616
• Apo-Clorazepate
• Azene
• Belseren
• Bipotassium chlorazepate
• Cb 4306
• Chlorazepate
• Chlorazepate Dipotassium
• Chlorazepate dipotassic
• Clorazepate potassium
• Cm 4306
• Dikalium chlorazepate
• Dipotassium chlorazepate
• Dipotassium clorazepate
• Gen-xene
• Mendon
• Nevracten
• Novo-Clopate
• Nu-Clopate
• Potassium hydroxide (K(OH)), compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1)
• Potassium hydroxide, compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1)
• Tencilan
• Tr 19119
• Transene
• Tranxene
• Tranxilen
• Tranxilene
• Tranxilium
• Tranzene
• [2-Phenyl-2-(2-amino-5-chlorophenyl)-1-azavinyl]malonic acid
• potassium 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylate hydroxypotassium (1:1:1)

Clorazepate.dipotassium.monohydrate

Prodotto controllato

CAS: 57109-90-7

Colore e forma: Neat

Ref: LP-CLR-120-HY-10

Clorazepate Dipotassium

Prodotto controllato

CAS: 57109-90-7

Applications Anxiolytic. Controlled substance (depressant).
References Cone, E., et al.: J. Pharm. Sci., 73, 243 (1984), Maurer, H., et al.: J. Anal. Toxicol., 25, 237 (2001), Beyer, J., et al.: Ther. Drug Monit., 27, 151 (2005),

Formula: C₁₆H₁₀ClN₂O₃·HKO·K

Colore e forma: White To Light Yellow

Peso molecolare: 408.92

Ref: TR-C587365

Clorazepate Dipotassium (1 mg/ml in Methanol)

Prodotto controllato

CAS: 57109-90-7

Formula: C₁₆H₁₀ClN₂O₃·HKO·K

Colore e forma: Colourless

Peso molecolare: 408.92

Ref: TR-KIT4162

Clorazepic acid dipotasium salt

Prodotto controllato

CAS: 57109-90-7

Please enquire for more information about Clorazepic acid dipotasium salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₁₆H₁₁ClK₂N₂O₄

Peso molecolare: 408.92 g/mol

Ref: 3D-C-2990

Clorazepic acid dipotasium salt

Prodotto controllato

CAS: 57109-90-7

Clorazepic acid dipotasium salt is a benzodiazepine with anticonvulsant and anxiolytic activity. It is metabolized to clorazepate, which has a longer half-life than the parent drug. Clorazepic acid dipotasium salt can be administered orally, intravenously, or intramuscularly. The drug is not active when taken orally and must be converted to clorazepate before it can exert its effects. Clorazepic acid dipotasium salt has been shown to have minimal toxicity in humans and animals. This drug has been shown to have a dose-dependent effect on δ receptors and serotonergic activity, but does not affect dopamine receptors or histamine H1 receptors. Clorazepic acid dipotasium salt binds to the benzodiazepine receptor site in the brain and decreases the frequency of seizures by inducing sedation

Formula: C₁₆H₁₁ClK₂N₂O₄

Purezza: Min. 95%

Colore e forma: Powder

Peso molecolare: 408.92 g/mol

Ref: 3D-FC20518

DIPOTASSIUM CLORAZEPATE MONOHYDRATE CRS - * PSY

Prodotto controllato

CAS: 57109-90-7

DIPOTASSIUM CLORAZEPATE MONOHYDRATE CRS - * PSY

Ref: 41-Y0002276

Clorazepate Dipotassium CIV

Prodotto controllato

CAS: 57109-90-7

Alprazolam(inn), camazepam (inn), chlordiazepoxide (inn), clonazepam (inn), clorazepate & other heterocyclic compounds with nitro atom(s) only

Formula: C₁₆H₁₁ClK₂N₂O₄

Colore e forma: White Light Yellow Crystalline Powder

Peso molecolare: 407.96815

Ref: 45-1140509